Versant Venture Management LLC

Versant Venture Management LLC latest Q1_2021 13F filings reported $513,262,000 in market value on this 2021-05-07 report date . The portfolio quarterly return is -46.70%. This fund has 11 securities concentrations of 100% weights.

Versant Venture Management LLC largest holding is CRISPR Therapeutics AG with weight of 36.92% and $189,472,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-05-072021-03-31Q1_202113F-HR11$513,262,000-46.70%
2021-02-162020-12-31Q4_202013F-HR12$962,968,00076.25%
2020-11-122020-09-30Q3_202013F-HR11$546,369,000-99.92%
2020-07-202020-06-30Q2_202013F-HR12$696,065,245,00090.89%
2020-04-282020-03-31Q1_202013F-HR9$364,636,407,0009.88%
2020-01-212019-12-31Q4_201913F-HR7$331,845,612,00028.40%
2019-10-082019-09-30Q3_201913F-HR8$258,454,717,000-24.69%
2019-07-122019-06-30Q2_201913F-HR9$343,186,489,00013.05%
2019-04-052019-03-31Q1_201913F-HR9$303,568,716,00050.27%
2019-01-222018-12-31Q4_201813F-HR10$202,020,917,000-31.29%
2018-10-052018-09-30Q3_201813F-HR10$294,005,109,000-8.27%
2018-07-132018-06-30Q2_201813F-HR9$320,525,517,0002.51%
2018-05-032018-03-31Q1_201813F-HR8$312,675,947,000229.03%
2018-01-252017-12-31Q4_201713F-HR7$95,029,118,000-27.67%
2017-10-132017-09-30Q3_201713F-HR8$131,378,620,0003.34%
2017-08-022017-06-30Q2_201713F-HR8$127,127,265,000-7.55%
2017-04-072017-03-31Q1_201713F-HR8$137,509,477,00033.84%
2017-01-182016-12-31Q4_201613F-HR7$102,740,818,00014.55%
2016-10-242016-09-30Q3_201613F-HR7$89,691,642,000-9.10%
2016-07-282016-06-30Q2_201613F-HR5$98,672,514,000-42.26%
2016-05-052015-12-31Q4_201513F-HR/A7$170,904,743,0000.00%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
CRISPR THERAPEUTICS AGCRSPDECR$189,472-0.59%36.92%$121.85-0.49%1,554,960
PASSAGE BIO INCPASGBUY$86,6970.00%16.89%$17.480.00%4,959,769
ALIGOS THERAPEUTICS INCALGSDECR$74,868-0.18%14.59%$22.740.00%3,292,339
ADVERUM BIOTECHNOLOGIES INCADVMDECR$49,973-0.08%9.74%$9.860.01%5,068,233
GRITSTONE ONCOLOGY INCGRTSINCR$41,9701.39%8.18%$9.430.00%4,450,638
CRINETICS PHARMACEUTICALS INCRNXINCR$31,0280.08%6.05%$15.280.00%2,030,616
AKERO THERAPEUTICS INCAKRODECR$17,920-0.11%3.49%$29.01-0.21%617,727
FLEXION THERAPEUTICS INCFLXNDECR$11,726-0.74%2.28%$8.95-0.66%1,310,169
APREA THERAPEUTICS INCAPREBUY$6,4240.00%1.25%$5.100.00%1,259,662
CYMABAY THERAPEUTICS INCCBAYDECR$2,469-0.21%0.48%$4.540.00%543,753
CLOVIS ONCOLOGY INCCLVSINCR$7150.46%0.14%$7.020.00%101,855
INARI MED INCNARISOLD$00.00%-100.00%$0.000.00%0
OCULAR THERAPEUTIX INCOCULSOLD$00.00%-100.00%$0.000.00%0